Free tool
Stocks listed on XETRA
We cover 32 companies listed on XETRA. The median market value in the group is $1.08B. Across the group, the median move over the past trading day is 0.00%. 55% of the 29 with a 200-day average trade above it. Price change over the past year runs from −38.9% to +70.6% across the middle 80 percent of the group, with a median of −4.0%.
Other lists in this group
Table
32 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| WDH1.DE | Demant A/S | 39.10 EUR | +2.84% | +36.62% | −5.53% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% |
| AFX.DE | Carl Zeiss Meditec AG | 31.92 EUR | +6.33% | −17.62% | −24.83% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% |
| BV3.DE | Bavarian Nordic A/S | 29.26 EUR | +23.46% | +13.19% | +15.65% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% |
| GXE.DE | Lakefront Biotherapeutics NV | 24.68 EUR | +0.82% | −12.36% | −44.50% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | 82.40 EUR | +8.42% | +52.87% | +53.42% |
| RDC.DE | Redcare Pharmacy NV | 62.05 EUR | −10.46% | −6.06% | −23.82% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | 14.70 EUR | +13.08% | +15.81% | +24.49% |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% |
| EUZ.DE | Eckert & Ziegler SE | 13.18 EUR | −4.56% | −12.19% | −24.60% |
| EVT.DE | Evotec SE | 3.25 EUR | −6.22% | −41.07% | −45.75% |
| 2HQ0.DE | Tilray Brands, Inc. | 4.07 EUR | +21.13% | −48.80% | −67.56% |
| AYJ.DE | Valneva SE | 2.98 EUR | +35.29% | −23.93% | −21.89% |
| FYB.DE | Formycon AG | 18.44 EUR | −2.64% | −29.35% | −25.04% |
| M12.DE | M1 Kliniken AG | 18.36 EUR | −2.86% | +1.10% | +37.84% |
| ILM1.DE | Medios AG | 10.92 EUR | −1.62% | −25.61% | −26.32% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | 13.50 EUR | +8.87% | −48.77% | +47.70% |
| MED.DE | MEDICLIN Aktiengesellschaft | 5.45 EUR | +31.64% | +51.39% | +75.81% |
| XUP.DE | Genfit S.A. | 14.08 EUR | −1.81% | +164.41% | +166.82% |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% |
| LIK.DE | LIMES Schlosskliniken AG | 570.00 EUR | −0.87% | +58.33% | +70.66% |
| VME.DE | Viromed Medical AG | 6.50 EUR | −15.03% | +71.96% | +85.71% |
| HPHA.DE | Heidelberg Pharma AG | 2.52 EUR | −2.70% | +0.80% | −31.15% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.